首页> 美国卫生研究院文献>International Journal of Oncology >Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells
【2h】

Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells

机译:功能获得性microRNA筛选可鉴定miR-193a调节上皮性卵巢癌细胞的增殖和凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are a small class of non-coding RNAs that negatively regulate gene expression, and are considered as new therapeutic targets for treating cancer. In this study, we performed a gain-of-function screen using miRNA mimic library (319 miRNA species) to identify those affecting cell proliferation in human epithelial ovarian cancer cells (A2780). We discovered a number of miRNAs that increased or decreased the cell viability of A2780 cells. Pro-proliferative and anti-proliferative miRNAs include oncogenic miR-372 and miR-373, and tumor suppressive miR-124a, miR-7, miR-192 and miR-193a, respectively. We found that overexpression of miR-124a, miR-192, miR-193a and miR-193b inhibited BrdU incorporation in A2780 cells, indicating that these miRNAs affected the cell cycle. Overexpression of miR-193a and miR-193b induced an activation of caspase 3/7, and resulted in apoptotic cell death in A2780 cells. A genome-wide gene expression analysis with miR-193a-transfected A2780 cells led to identification of ARHGAP19, CCND1, ERBB4, KRAS and MCL1 as potential miR-193a targets. We demonstrated that miR-193a decreased the amount of MCL1 protein by binding 3′UTR of its mRNA. Our study suggests the potential of miRNA screens to discover miRNAs as therapeutic tools to treat ovarian cancer.
机译:微小RNA(miRNA)是一小类负面编码基因表达的非编码RNA,被认为是治疗癌症的新治疗靶标。在这项研究中,我们使用miRNA模拟文库(319个miRNA物种)进行了功能增益筛选,以鉴定那些影响人上皮性卵巢癌细胞(A2780)细胞增殖的分子。我们发现了许多增加或减少A2780细胞活力的miRNA。促增殖和抗增殖的miRNA分别包括致癌miR-372和miR-373,以及抑制肿瘤的miR-124a,miR-7,miR-192和miR-193a。我们发现miR-124a,miR-192,miR-193a和miR-193b的过表达抑制了A2780细胞中BrdU的掺入,表明这些miRNA影响了细胞周期。 miR-193a和miR-193b的过表达诱导caspase 3/7激活,并导致A2780细胞凋亡。使用miR-193a转染的A2780细胞进行全基因组基因表达分析,可确定ARHGAP19,CCND1,ERBB4,KRAS和MCL1作为潜在的miR-193a靶标。我们证明了miR-193a通过结合其mRNA的3'UTR减少了MCL1蛋白的量。我们的研究表明,miRNA筛选可能发现miRNA作为治疗卵巢癌的治疗工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号